MedPath

A Comparative Evaluation of Augmentation of Compromised Alveolar Socketusing Albumin Platelet Rich Fibrin Block –A Randomised Controlled Trial.

Phase 3
Conditions
Health Condition 1: K055- Other periodontal diseasesHealth Condition 2: K055- Other periodontal diseases
Registration Number
CTRI/2024/08/072532
Lead Sponsor
Dr Niveditha M
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

General indications-

1. Male and female patients with in the age group of 20-55years.

2. Patient with no systemic diseases (Eg. -uncontrolled diabetes, uncontrolled hypertension and bleeding disorders)

3. Patient with good oral hygiene.

Site specific indications:

1. Maxillary and mandibular anterior teeth and premolars that are indicated for extraction with buccal bone loss (Type II defect).

2. Periodontally hopeless teeth indicated for extraction.

3. The adjacent teeth should have a good periodontal health.

Exclusion Criteria

1. who are smokers, alcoholics or tobacco chewers.

2. Patients not willing to participate in the study or not available for follow up.

3. Pregnant and lactating women

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To clinically evaluate the vertical height and horizontal width of the alveolar bone with or without <br/ ><br>Albumin-PRF block in compromised (Kim’s type II) extraction sockets at baseline and 4 months <br/ ><br>postoperatively.Timepoint: 4 months
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath